Our take on current developments and stories in the news.
JMIR Publications published the preprint of Triall's research paper on blockchain-based dynamic consent with Mayo Clinic physician Dr. McLeod.
According to The Economist, as much as 1 in 50 research papers includes results which are unreliable because of fabrication, plagiarism, or serious errors.
Triall CEO Hadil Es-Sbai authored an article for Applied Clinical Trials magazine, one of the leading industry journals for clinical research professionals.
Despite policy efforts to improve patient diversity in clinical research, under-representation of women, older adults, and racial & ethnical minorities remains a persistent problem.
Two clinical trial coordinators have been sentenced to prison after data falsifications scheme.
Triall featured in Forbes Magazine with a spotlight article on our platform and blockchain-enabled vision for clinical research.
Triall's recent collaboration with Mayo Clinic has been covered by Healthcare IT News in an article written by senior editor Andrea Fox.
According to Science Magazine, several hallmark scientific papers on the origin of Alzheimer’s show clear signs of image tampering.
The Triall Newsletter provides a concise overview of product innovation updates, upcoming events, and anything else Triall-related.